Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Citadel Group M&A Activity 2020

Aug 25, 2020

10454_mrq_2020-08-25_126bd666-e150-4a1f-9a59-a25a0bb0abc2.html

M&A Activity

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 0822X

Citadel Group

25 August 2020

Ap 19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.         KEY INFORMATION

Name of person dealing (Note 1)

Citadel Group

Company dealt in

WILLIS TOWERS WATSON PLC

Class of relevant security to which the dealings being disclosed relate (Note 2)

Common Stock ISIN IE00BDB6Q211

Date of dealing

24 August, 2020

2.         INTERESTS AND SHORT POSITIONS

(a)        Interests and short positions (following dealing) in the class of relevant security

dealt in (Note 3)

Long Short
Common Stock  ISIN  IE00BDB6Q211 Number        (%) Number      (%)
(1) Relevant securities 566,211 (0.44%) 1 (0.00%)
(2) Derivatives (other than options) 1,446,529 (1.12%) 0 (0.00%)
(3) Options and agreements to purchase/sell 0 (0.00%) 0 (0.00%)
Total 2,012,740(1.56%) 1 (0.00%)

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Long Short
Number        (%) Number      (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap 20

1.         DEALINGS (Note 4)

(a)        Purchases and sales

Purchase/sale

Common Stock ISIN IE00BDB6Q211
Number of securities Price per unit (Note 5)
Purchase 70 193.45614286  USD
Purchase 501 194.03195609  USD
Purchase 175 194.38714286  USD
Purchase 160 194.49875  USD
Purchase 97 194.56  USD
Purchase 10 194.65  USD
Purchase 425 194.86670588  USD
Purchase 734 194.86681199  USD
Purchase 8 194.93  USD
Purchase 100 195.08  USD
Purchase 2,500 195.416208  USD
Purchase 18 195.55222222  USD
Purchase 681 195.71192364  USD
Purchase 1,440 195.83621528  USD
Purchase 1,606 195.90235056  USD
Purchase 210 195.94095238  USD
Purchase 199 195.95  USD
Purchase 329 196.01  USD
Purchase 903 196.02555925  USD
Purchase 230 196.04434783  USD
Purchase 300 196.46666667  USD
Purchase 93 198.09  USD
Sale -97 194.33  USD
Sale -227 194.43070485  USD
Sale -236 194.6  USD
Sale -2 194.79  USD
Sale -278 195.63172662  USD
Sale -557 195.64287253  USD
Sale -196 195.85880102  USD
Sale -2,844 195.88192686  USD
Sale -814 195.88585995  USD
Sale -3,112 195.88819409  USD
Sale -185 195.97  USD
Sale -25 196  USD
Sale -288 196.00833333  USD
Sale -88 196.13  USD
Sale -592 196.15202703  USD
Sale -100 196.19  USD
Sale -103 196.205  USD
Sale -15 196.34  USD
Sale -222 196.92193694  USD
Sale -100 197.37  USD

(b)        Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

 ISIN
Nature of transaction

(Note 6)
Number of relevant securities

(Note 7)
Price per unit

(Note 5)

(c)        Options transactions in respect of existing relevant securities

(i)         Writing, selling, purchasing or varying

Product name, e.g. call option Writing, selling, purchasing,

varying etc.
Number of securities to which the option relates (Note 7) Exercise price Type,

e.g. American, European etc.
Expiry date Option money paid/ received per unit

(Note 5)

(ii)        Exercising

Product name,

e.g. call option
Number of securities Exercise price per unit

(Note 5)

(d)        Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)
Details Price per unit

      (if applicable) (Note 5)

Ap 21

2.         OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated
None

Is a Supplemental Form 8 attached? (Note 9)

NO

Date of disclosure: 25 August, 2020
Contact name: Katie Bonds
Telephone number: 020 7645 9700
If a connected EFM, name of offeree/offeror with which connected n/a
If a connected EFM, state nature of connection (Note 10) n/a

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ISEEAPPSADSEEEA